Pharmacogenetic test strip StripAssay®

pharmacogenetic test strip
pharmacogenetic test strip
Add to favorites
Compare this product


for pharmacogenetics
Tested parameter


Highly active retroviral therapy (HAART) is a very effective treatment for HIV-positive patients. Allelic variants of certain proteins have been associated with successful HAART. The PGX-HIV StripAssay® identifies variants in genes known to be relevant for effective HAART. HAART has brought about substantial improvements to HIV-positive patients and has led to a significant reduction in AIDS-related mortality in countries with access to the treatment. Allelic variants of the multidrug transporter P-glycoprotein 1 (MDR1), cytochrome P450 isozyme 2D6 (CYP2D6), and the C-C chemokine receptor 5 (CCR5) are known to be associated with the best possible outcome of HAART. Identification of relevant genetic variations supports better guidance of HIV therapy. The PGX-HIV StripAssay® identifies genetic variants, which influence the efficacy of HAART, and can help to adjust therapy to individual needs.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.